Skip to content

A Simplified Test to Assess Flavor in COVID-19 Patients

Simplified Flavor Test for Self-administation in COVID-19 Positive Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04840966
Enrollment
111
Registered
2021-04-12
Start date
2020-05-05
Completion date
2021-01-15
Last updated
2021-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

flavor, smell, flavor test, hyposmia, retro-nasal olfaction

Brief summary

The Flavor test has been developed and validated by our group to assess retro-nasal olfactory performances. The original flavor test has been simplified, with the great advantage to be self-administrable for COVID-19 patients in isolation, without any risk to health professionals.

Detailed description

Smell and taste dysfunctions (STDs) are symptoms associated with COVID-19 syndrome, even if their incidence is still uncertain and variable. In this study, the effects of SARS-CoV-2 infection on chemosensory function have been investigated using both a self-reporting questionnaire on smell and flavor perception, and a simplified flavor test. A total of 111 subjects (19 hospitalized \[HOS\] and 37 home-isolated \[HI\] COVID-19 patients, and 55 healthy controls \[CTRL\]) were enrolled in the study. The flavor test used consists in the self-administration of four solution with a pure olfactory stimulus (coffee), a mixed olfactory-trigeminal stimulus (peppermint), and a complex chemical mixture (banana). After SARS-CoV-2 infection, HOS and HI patients reported similar frequency of STDs, with a significant reduction of both smell and flavor self-estimated perception. The aromas of the Flavor test were recognized by HI and HOS COVID-19 patients similarly to CTRL, however the intensity of the perceived aromas was significantly lower in patients compared to controls. This suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified flavor test could be a novel self-administering objective screening test to assess STDs in COVID-19 patients.

Interventions

DIAGNOSTIC_TESTFlavor test

A simplified self-administrable flavor test has been proposted to all the enrolled subjects

OTHERSelf-assesment questionnaire

Questionnaire to score subjective chemosensory function (smell and flavor) before and after COVID-19 using a 0-10 scale with 0 corresponding to no smell/flavor perception and 10 corresponding to excellent smell/flavor perception.

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adults (≥18 years of age) that gave their written informed consent to the study * Diagnosis of COVID-19 was confirmed by PCR of nasopharyngeal swab (HI or HOS) * Negative COVID-19 nasopharyngeal swab (CTRL) * Subjects with no critical conditions and able to understand the protocol

Exclusion criteria

* nasal obstruction or previous nasal diseases

Design outcomes

Primary

MeasureTime frameDescription
Flavor perceptionApr, 2020- Jan, 2021To assess qualitative flavor perception

Secondary

MeasureTime frameDescription
Flavor perception intensityApr, 2020- Jan, 2021To assess quantitative flavor perception

Other

MeasureTime frameDescription
Comparison with self-estimated flavor perceptionApr, 2020- Jan, 2021To compare results of the test with self-assessed flavor and smell perception

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026